CHPA unveils medicines abuse awareness campaign

21 May 2006

The US Consumer Healthcare Products Association has unveiled a multi-pronged effort to curb the abuse of prescription and over-the-counter medicines and draw public attention to this troubling substance abuse trend among teenagers. A major component of this initiative is a national public awareness campaign created in cooperation with the Partnership for a Drug-Free America.

It says that research conducted by the Partnership for a Drug-Free America shows that teens across the nation are looking to their family medicine cabinets in an effort to get high. In addition to certain prescription drugs, a surprising number of teens are intentionally abusing OTC cough medicines containing dextromethorphan. This form of abuse involves taking extreme amounts of cough medicine to get high.

"It's important that parents understand that that their children may be abusing - by taking exceedingly higher doses than what is recommended - the very medicines that we use to safely and effectively treat common everyday ailments," said Linda Suydam, president of the CHPA. "The goal of the OTC medicine makers in supporting this campaign is to make parents more aware and encourage them to talk to their kids so we can put a stop to this abuse and prevent it from continuing," she added.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight